August 9 – Business Development Bank of Canada – Press Release
Clementia Pharmaceuticals, a Montreal-based biopharmaceutical company successfully completed a USD $120M million IPO on NASDAQ last week, following in the footsteps of Zymeworks, who completed its IPO in June, highlighting the growing momentum of the Canadian biotech sector. “If more Canadian companies emulate Zymeworks and Clementia utilizing public markets to raise large rounds to finance growth, … Read more